Last reviewed · How we verify
NCT04581642: MoNOLog
Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report
trial testing PMD200 in Pain in 33 participants. Completed in 30 November 2021.
30 August 2021
Quick facts
| Lead sponsor | Medasense Biometrics Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 33 |
| Start date | 1 November 2020 |
| Primary completion | 30 August 2021 |
| Estimated completion | 30 November 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- PMD200
Conditions studied
- Pain — all drugs for Pain →
- Opioid Use — all drugs for Opioid Use →
- Dementia — all drugs for Dementia →
- Unconscious — all drugs for Unconscious →
Sponsor
Medasense Biometrics Ltd — full company profile →
Who can join
18 and older, any sex, with Pain or Opioid Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study we aimed to investigate the performance and effectiveness of NOL and/or NOLedge as a tool for pain assessment in geriatric and critical ill non communicating patients. Our hypothesis was that NOL and the NOLedge may have good correlation with the health-care professional assessment PAINAD, BPS values, even with the use of the drugs affecting autonomic nervous system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04581642
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Medasense Biometrics Ltd trials
Trials by the same sponsor.
- NCT04305015 — Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot · NA · completed
- NCT03970291 — Impact of NOL Intraoperative Guided Fentanyl Analgesia vs SCC for Elective Major Abdominal Surgery · NA · completed
- NCT03389048 — Performance Assessment Of The PMD-200 In Subjects With Degenerative Lumbar Spine Disease Who Requires Surgical Procedure · NA · terminated
- NCT03452163 — Performance Assessment of the PMD-200 in Subjects at Neurointensive Care Unit · NA · terminated
- NCT03276260 — Evaluation of Medasense's PMD-200 During Surgery and Post Anesthesia Care · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04581642 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medasense Biometrics Ltd
- Last refreshed: 14 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04581642.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing